TrialKidney3602021

A Non-purine Xanthine Oxidoreductase Inhibitor Reduces Albuminuria in Patients with DKD: A Randomized Controlled Trial.

George L Bakris et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.